| Patents for C07C 317 - Sulfones; Sulfoxides (15,874) |
|---|
| 02/16/2005 | EP1506170A1 Method for producing bicalutamide |
| 02/16/2005 | EP1425258A4 Hydroxyeicosenoic acid analogs |
| 02/16/2005 | EP1215203B1 Hydroxamic acid derivatives, process for the production thereof and drugs containing the same as the active ingredient |
| 02/16/2005 | CN1582269A Hydroxyeicosenoic acid analogs |
| 02/15/2005 | US6855843 Antihistamines; rheumatic diseases; antidiabetic agents; inflammatory bowel disorders |
| 02/15/2005 | US6855832 O- or S-substituted tetrahydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity |
| 02/15/2005 | US6855831 Converting substituted mono or bicyclic lactones in presence of an amine base and a catalytic amount of a cyanide or alkali or alkaline metal alcoholate, to a salt, reacting the salt with carbonyl compound containing an organic substituent |
| 02/15/2005 | US6855706 Phenylalanine derivatives |
| 02/10/2005 | WO2005012220A2 Cycloalkylidene compounds as modulators of estrogen receptor |
| 02/10/2005 | US20050033082 Method for producing bicalutamide |
| 02/10/2005 | US20050032796 Compounds as for example, 2'-[1-[(2R)-3-[[1-(3-fluoro-4-methylphenyl)-2-methylpropan-2-yl]amino]-2-hydroxypropoxy]ethyl]-3-methylbiphenyl-4-carboxylic acid, having a calcium-sensing receptor antagonistic action; therapeutic drug for osteoporosis |
| 02/09/2005 | EP1505054A1 Process for producing 4-phenyl-4-oxo-2-butenoic ester derivative |
| 02/09/2005 | EP1503983A1 A process for the preparation of modafinil |
| 02/09/2005 | EP1503981A2 Substituted tetracycline compounds |
| 02/09/2005 | EP1436252A4 Hydroxyfattysulfonic acid analogs |
| 02/09/2005 | EP1206318B1 Perfluorosulfonylmethide compounds; use thereof for carbon-carbon bond formation |
| 02/09/2005 | CN1578779A Small organic molecule regulators of cell proliferation |
| 02/09/2005 | CN1578765A Method of preparing 4-chloro-3-methyl-2-butenylphenyl sulfide, di4-chloro-3-methyl-2-butenylsulfide and di4-chloro-3-methyl-2-butenylsulfone for synthesis of natural carotenoid products |
| 02/09/2005 | CN1578764A Process for the preparation of 2-[alkyl(aryl)]sulfonylbenzene-sulfonyl chlorides and their intermediates |
| 02/09/2005 | CN1188420C Fungicides for preventing and curing full rot disease of plants |
| 02/09/2005 | CN1188419C Fungicides for control of full-rot disease of plants |
| 02/09/2005 | CN1188392C Process for synthesis of hydrocarbonfluoride |
| 02/09/2005 | CN1188121C Therapeutic substituted guanidines |
| 02/08/2005 | US6852750 Spinal cord injury, demyelinating diseases, Parkinson's disease, Amyotrophic Lateral Sclerosis, alcohol, nicotine, cocaine dependence, neuropathy, pain and schizophrenia; antiischemic, - carcinogenic agents; NAALADase inhibitors |
| 02/08/2005 | US6852747 Resorcinol derivatives |
| 02/08/2005 | CA2096525C Retroviral protease inhibitors |
| 02/08/2005 | CA2096409C Retroviral protease inhibitors |
| 02/08/2005 | CA2096408C Retroviral protease inhibitors |
| 02/03/2005 | WO2005009946A1 Process for purifying and isolating rac-bicalutamide |
| 02/03/2005 | WO2005009940A1 Novel aminobenzophenone compounds |
| 02/03/2005 | WO2005009429A1 Compositions containing prodrugs of florfenicol and methods of use |
| 02/03/2005 | WO2004074242A3 Halogenated oxime derivatives and the use thereof as latent acids |
| 02/03/2005 | CA2531223A1 Compositions containing prodrugs of florfenicol and methods of use |
| 02/03/2005 | CA2530302A1 Novel aminobenzophenone compounds |
| 02/03/2005 | CA2529232A1 Process for purifying and isolating rac-bicalutamide |
| 02/02/2005 | EP1501792A2 Catalytic process for preparing perfluoroethanesulfonyl fluoride and/or perfluorodiethylsulfone |
| 02/02/2005 | CN1575279A Substituted thioacetamides |
| 02/02/2005 | CN1575275A Novel alpha-oxygenated or alpha-thiolated carboxylic acid penethylamide derivatives |
| 02/02/2005 | CN1187323C Process for producing alkylsulfonylbenzaldehyde |
| 02/01/2005 | US6849763 Reacting 4-fluorothiophenol in methanol, adding methyl-1,2-epoxy-2-methylpropionate and ethyl acetate, recovering 2-hydroxy-2-methyl-3-(4-fluorophenylthio)propionic acid, then solidifying |
| 02/01/2005 | US6849744 3-(substituted phenyl),4-substituted-5H-1,2-oxathiole 2-oxide or 2,2-dioxide compounds useful as agricultural fungicides, insecticides, herbicides |
| 02/01/2005 | US6849648 Phenylene alkyne matrix metalloproteinase inhibitors |
| 02/01/2005 | US6849626 Aza-amino acid derivatives (factor Xa inhibitors 15) |
| 02/01/2005 | US6849120 Oxidizing 2-((diphenylmethyl)thio)acetamide with hydrogen peroxide in mixture of mineral acid with alcohol or phase transfer catalyst, precipitating solid, and separating |
| 02/01/2005 | CA2362698C Resorcinol derivatives |
| 02/01/2005 | CA2276719C Anilide derivatives and antiarrhythmic agents containing the same |
| 01/27/2005 | WO2005007621A2 Ubiquitin ligase inhibitors |
| 01/27/2005 | WO2004075827A3 Process for the preparation of 2-[(diphenylmethyl) thio] acetamide |
| 01/27/2005 | US20050020680 Hydroxyfattysulfonic acid analogs |
| 01/27/2005 | US20050020675 N-[4-cyano-3-(trifluoro-methyl) phenyl]-3-[(4-fluorophenyl)sulfonyl]-2-hydroxy-2-methylpropanamide in crystalline form and amorphous bicalutamide; for use in treatment of prostate cancer |
| 01/27/2005 | US20050020651 Butyric acid derivatives |
| 01/27/2005 | US20050020584 Benzamide derivatives as antagonists of orexin receptors |
| 01/27/2005 | US20050020504 C-terminal modified oxamyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteases |
| 01/27/2005 | US20050020450 Novel alpha-oxygenated or alpha-thiolated carboxylic acid penethylamide derivatives |
| 01/26/2005 | EP1500643A1 Benzamide derivatives |
| 01/26/2005 | EP1499577A1 2-(2,6-dichlorophenyl)-diarylimidazoles |
| 01/26/2005 | CN1569829A Method for preparing 2-amino-4-methylthio-(s-oxo-s-imino)-butyric acid phosphate or succinate |
| 01/26/2005 | CN1569826A Method for hydrolysis of 1, 2-bis(3'-nitrobenzene sulphone group )ethane byproduced in the production of 3-(beta-hydroxy ethylsulphonyl)nitrobenzene |
| 01/26/2005 | CN1186315C O-anisamide derivatives |
| 01/25/2005 | US6846954 α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors |
| 01/25/2005 | US6846813 For inhibiting beta-secretase enzyme activity and A beta peptide production, inhibition of beta-secretase enzyme activity halts or reduces production of A beta from APP and reduces or eliminates the formation of beta-amyloid deposits |
| 01/20/2005 | WO2004066940A3 Compositions and methods containing substituted quinolines and substituted diphenylsulfones |
| 01/20/2005 | US20050014941 Cyanoalkylamino derivatives as protease inhibitors |
| 01/20/2005 | US20050014917 Used in electrochemical applications such as fuel cells, electrodialysis; separators; catalyst for Diels-Alder reactions; Friedel-Craft catalyst; fluoropolymers |
| 01/20/2005 | US20050014828 Compositions containing prodrugs of florfenicol and methods of use |
| 01/19/2005 | EP1498412A1 Process for producing dihydroxydiphenyl sulfone |
| 01/19/2005 | EP1497272A2 Method of preparing amine stereoisomers |
| 01/19/2005 | EP1497261A1 Phenethanolamine derivatives |
| 01/19/2005 | EP1497251A1 3-keto or 3-oximoether substituted benzoylcyclohexanediones |
| 01/19/2005 | CN1568309A 4'-methanesulfonyl-biphenyl derivatives as a highly selective cyclooxygenase-2 inhibitor |
| 01/19/2005 | CN1185223C Novel Compounds and methods for synthesis and therapy |
| 01/19/2005 | CN1185219C Trans olefinic glucokinase activators |
| 01/19/2005 | CN1185108C Heat sensitive recording material |
| 01/18/2005 | US6844367 Benzamides and related inhibitors of factor Xa |
| 01/18/2005 | US6843978 Microporous materials (TIQ-6 and METIQ-6) of high surface area active in oxidation reactions |
| 01/13/2005 | WO2003078390A8 Phenolic compound and recording material containing the same |
| 01/13/2005 | US20050009871 Ubiquitin ligase inhibitors |
| 01/13/2005 | US20050009816 Potassium channel modulators |
| 01/12/2005 | EP1494998A2 Multiple-component solid phases containing at least one active pharmaceutical ingredient |
| 01/12/2005 | EP1494989A2 Compounds that modulate ppar activity and methods for their preparation |
| 01/12/2005 | CN1184214C Alpha-acyl and alpha-heteroatom-bustituted benzene acetamide glucokinase activators |
| 01/12/2005 | CN1184206C Prepn process of pyrazole derivative |
| 01/12/2005 | CN1184200C Bi-aromatic compounds bond by a heteroethynytene radical and pharmaceutical and comsmetic compositions containing same |
| 01/12/2005 | CN1184197C 荧光增白剂 Fluorescent Brightener |
| 01/11/2005 | US6841304 Dissolves other salts, in particular metallic salts, such as lithium salts, to give highly conductive solutions |
| 01/06/2005 | WO2005000834A1 Pentafluoroalkanesulfinyl naphthalenes and related estrogen receptor modulators |
| 01/06/2005 | WO2005000799A1 Process for preparing polymorphic form (i) of modafinil |
| 01/06/2005 | WO2005000798A1 Heterocyclic methyl sulfone derivative |
| 01/06/2005 | WO2004094650A3 Synthesis of labeled metabolites |
| 01/06/2005 | US20050004379 Chemical intermediates for drugs; neurological disorders; psychological disorders |
| 01/06/2005 | US20050004116 Triazole inhibitors of type 2 methionine aminopeptidase |
| 01/06/2005 | US20050004038 Therapy for drug resistant cancer, malaria,hematopoiesis |
| 01/06/2005 | CA2526487A1 Heterocyclic methyl sulfone derivative |
| 01/05/2005 | EP1492774A2 Pyrimidone derivatives useful for the treatment of inflammation and immunological diseases |
| 01/05/2005 | EP1492757A1 (2-((2-alkoxy)-phenyl)-cyclopent-1-enyl) aromatic carbo- and heterocyclic carboxylic acid and derivatives |
| 01/05/2005 | EP1243333B1 High surface microporous materials which are active in oxidation reactions. tiq-6 and metiq-6 |
| 01/05/2005 | CN1561332A Preparation of HIV protease inhibitors |
| 01/05/2005 | CN1561331A Diaryl sulfide derivative, addition salt thereof, and immunosuppressant |
| 01/05/2005 | CN1561327A Novel aminobenzoephenones |
| 01/05/2005 | CN1561246A Compositions of cyclooxygenase-2 selective inhibitors and radiation for inhibition or prevention of cardiovascular disease |